
via Shirley Ryan AbilityLab
A team of scientists — led by Yamin Zhang, PhD, and Colin Franz, MD, PhD, at Shirley Ryan AbilityLab and John Rogers, PhD, at Northwestern University — has developed novel technology with the potential to change the future of drug delivery.
The device developed represents the first implantable drug delivery system that is triggered by external light sources of different wavelengths, and not by electronics. It also is the first to be absorbable by the body (avoiding surgical extraction) while still allowing active control and programming by the operator (e.g., a doctor, nurse or patient). A study highlighting the device has been published today in the Proceedings of the National Academy of Sciences (PNAS).
“This technology represents a breakthrough addressing shortfalls of current drug delivery systems — one that could have important and sweeping implications for everything from the opioid epidemic to how cancer treatments are precisely delivered,” said Colin Franz, MD, PhD, physician-scientist at Shirley Ryan AbilityLab.
Current implantable drug delivery systems are used to treat medical conditions ranging from chronic pain and muscle spasticity to cancer and diabetes. Passive systems enable gradual release of drugs and don’t require extraction at the end of their use, but they cannot be actively controlled by the user (e.g., turning drug delivery off, up or down). Conversely, active systems that allow programmable drug release require power supplies and electronic parts, and eventually require a second surgery for device extraction.
To test this novel technology, researchers surgically implanted it into the right sciatic nerve of individual rats. Each device contained three drug reservoirs filled with lidocaine, a common nerve-pain-blocking drug. Then, three LEDs were placed over the implantation sites to trigger release of the drug. Subsequent testing showed marked pain relief among the rats. Moreover, researchers were able to achieve different patterns of pain relief depending on the LED color-light sequencing.
“We found this approach to be an effective, safe and non-addictive alternative to systemically delivered pain medications,” said Northwestern University’s John Rogers, PhD. “Additionally, it can be scaled. Although we used a combination of three LEDs in our proof-of-concept testing, moving forward we can potentially increase it up to 30 different LED wavelengths, offering many more programs for pain relief.”
In future studies, the scientific team will review various safety elements prior to seeking U.S. Food and Drug Administration (FDA) clearance for human clinical trials.
“This technology has many promising implications in rehabilitation medicine and beyond, and the collaboration among physicians, material scientists and biomedical engineers at Shirley Ryan AbilityLab and Northwestern University is rapidly accelerating clinically relevant discoveries,” said Dr. Franz, who also is an assistant professor of Physical Medicine and Rehabilitation and Neurology at Northwestern University Feinberg School of Medicine.
Original Article: Shirley Ryan AbilityLab and Northwestern University Invent Self-Powered Drug Delivery System
More from: Shirley Ryan AbilityLab | Northwestern University
The Latest Updates from Bing News
Go deeper with Bing News on:
Implantable drug delivery system
- Chinese researchers develop implantable device for in vivo drug delivery
LANZHOU, Nov. 22 (Xinhua) --Researchers have developed a soft implantable device with integrated wireless charging and Zinc-ion hybrid supercapacitors that can be used for in vivo drug delivery, ...
- Chinese researchers develop implantable device for in vivo drug delivery
Its power supply capabilities have also been successfully demonstrated for controlled in vivo drug delivery, he added ... worked together on the study and developed the soft implantable power system, ...
- Revolutionary wireless charger can power medical implants inside human body
A team of scientists at Lanzhou University, China, has created a wireless charger capable of powering bioelectronic implants, such as fully biodegradable drug delivery systems ...
- Under the skin: Chinese scientists create wireless charger that can stay safely in human body
A prototype has been created for a wireless implantable power system that is biodegradable and flexible. After showing positive test results, scientists hope the system will eventually be used to ...
- Implantable Drug Delivery Systems, Ingestible Sensors and Digital Pills
Articles published in 2022-implantable-drug-delivery-systems-ingestible-sensors-and-digital-pills&text=Check out this fascinating @jmirpub ecollection of articles: Implantable Drug Delivery Systems, ...
Go deeper with Bing News on:
Drug delivery system
- Ocular Drug Delivery Market to reach $115.5 Billion, Globally, by 2032 at 5.5% CAGR: Allied Market Research
Increase in technological advancement, rise in prevalence of eye disorders, and surge in old age population drive the growth of the ocular drug delivery market. PORTLAND, Ore., Dec. 4, 2023 ...
- Revolutionary 'anthrobots' from human cells: A leap in healing and drug delivery
In a groundbreaking study, scientists have developed "anthrobots" from adult human lung cells, capable of autonomous movement and initiating wound healing in human neurons.
- Global Oral Controlled Release Drug Delivery Technology Market is set to reach a Staggering US$ 68.4 Billion By 2032 | FMI
By 2032, the oral controlled release drug delivery technology market is projected to have grown from US$ 34.1 billion in 2022 to US$ 68.4 billion. It is expected that global consumption will increase ...
- How can drug delivery systems be optimized for skin compatibility?
The skin consists of three main layers: the epidermis, the dermis, and the subcutaneous tissue. The epidermis is the outermost layer that protects the body from external agents, such as microbes ...
- Hydrogel system may reduce daily Ozempic or Wegovy use in type 2 diabetes
Share on Pinterest A new drug delivery system could reduce the frequency of shots required to manage type 2 diabetes. John Fredricks/NurPhoto via Getty Images Dealing with daily or weekly ...